Fanis, Pavlos <br/><br/>
A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β-thalassemia major.  [electronic resource] 

 -  Human mutation  10 2019 
 - 1768-1780 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-1004 
<br/><br/><label>Standard No.: </label>10.1002/humu.23817  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alleles<br/>Biomarkers<br/>DNA Mutational Analysis<br/>Erythrocyte Indices<br/>Female<br/>Fetal Hemoglobin--genetics<br/>Genetic Association Studies<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Humans<br/>Kruppel-Like Transcription Factors--chemistry<br/>Male<br/>Middle Aged<br/>Models, Molecular<br/>Mutation<br/>Pedigree<br/>Phenotype<br/>Protein Conformation<br/>Severity of Illness Index<br/>Structure-Activity Relationship<br/>Symptom Assessment<br/>beta-Globins--genetics<br/>beta-Thalassemia--blood